↓ Skip to main content

A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 X users
patent
1 patent

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy
Published in
Journal for Immunotherapy of Cancer, December 2018
DOI 10.1186/s40425-018-0481-0
Pubmed ID
Authors

Alice Horisberger, Stefano La Rosa, Jean-Philippe Zurcher, Stefan Zimmermann, Francois Spertini, George Coukos, Michel Obeid

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 16%
Student > Master 8 13%
Other 7 11%
Student > Bachelor 6 10%
Student > Ph. D. Student 3 5%
Other 7 11%
Unknown 20 33%
Readers by discipline Count As %
Medicine and Dentistry 24 39%
Nursing and Health Professions 5 8%
Biochemistry, Genetics and Molecular Biology 4 7%
Unspecified 2 3%
Computer Science 1 2%
Other 3 5%
Unknown 22 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2021.
All research outputs
#6,502,063
of 25,775,807 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,548
of 3,513 outputs
Outputs of similar age
#122,214
of 448,165 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#52
of 80 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 3,513 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,165 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.